About Biscayne Pharma
Biscayne Pharma is a company based in Miami (United States) founded in 2012 was acquired by Supernus Pharmaceuticals in September 2018. Biscayne Pharma has raised $10.53 million across 5 funding rounds from investors including Supernus Pharmaceuticals, GF Securities and Quark Venture. Biscayne Pharma offers products and services including Health Blogs and Supplements Information.
- Headquarter Miami, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$10.53 M (USD)
in 5 rounds
-
Latest Funding Round
$3 M (USD), Series B
Jan 27, 2017
-
Investors
Supernus Pharmaceuticals
& 4 more
-
Employee Count
Not available
-
Acquired by
Supernus Pharmaceuticals
(Sep 13, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biscayne Pharma
Biscayne Pharma offers a comprehensive portfolio of products and services, including Health Blogs and Supplements Information.
Delivers articles on wellness, meditation, and health tips.
Provides details on supplements like CBD oil and pain relief options.
Funding Insights of Biscayne Pharma
Biscayne Pharma has successfully raised a total of $10.53M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $3 million completed in January 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Biscayne Pharma
Biscayne Pharma has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Supernus Pharmaceuticals, GF Securities and Quark Venture.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech & Life Sciences focused early stage VC firm investing in North America
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Provider of investment & asset management and financial services
|
Locked | Locked | Locked |
Investor details for Biscayne Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biscayne Pharma
Investment portfolio details for Biscayne Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Biscayne Pharma
Detailed financials for Biscayne Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biscayne Pharma Comparisons
Peer comparison for Biscayne Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biscayne Pharma
Detailed competitors of Biscayne Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biscayne Pharma
Complete news archive for Biscayne Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biscayne Pharma
Biscayne Pharma was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Biscayne Pharma is headquartered in Miami, United States. It is registered at Miami, Florida, United States.
Biscayne Pharma is a funded company, having raised a total of $10.53M across 5 funding rounds to date.
Biscayne Pharmaceuticals is a clinical stage drug development biotech focusing on CNS disorders (refractory epilepsy) and drug-resistant cancer. Biscayne acquired the CNS program, and the molecule BIS-001, as part of its merger with Insero Health in 2015. BIS-001, which has completed Phase I clinical studies, is an acetylcholinesterase inhibitor. The pipelines for cancer (BIS-1602 - Breast, endometrial, ovarian cancers) and cardiology are based on Growth hormone Releasing Hormone (GHRH) - based on Nobel Laureate Biscayne co-founder, Dr. Andrew Schallys research.
Biscayne Pharma offers Health Blogs and Supplements Information.
Biscayne Pharma has 5 investors. Key investors include Supernus Pharmaceuticals, GF Securities, Quark Venture, Mesa Verde Venture Partners, and Florida Institute.